An early phase, open label, multi-centre trial of front-line TheRapy for EBv-associated Lymphomas -- 2: TREBL-2 (Stream 6) (2022–2027)
- Grant type:
- NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
- Researchers:
-
-
- Funded by:
- Commonwealth Department of Health and Aged Care
